Hyperfine has initiated the launch of the next-generation Swoop® system in European markets, beginning the global expansion of its most advanced portable MRI technology.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the European launch of the next-generation Swoop® system powered by the latest advancement in Optive AI™ software. This marks a significant milestone in the company’s global expansion of its most advanced portable MRI technology, supporting international commercial growth and improving global access to high-quality brain imaging at the point of care.
Following CE mark and UKCA approval, the next-generation Swoop® system, also known as Model 2, is now commercially available across an initial wave of European markets.
Professor Steve Williams, Professor of Neuroimaging at King’s College London and Head of the Department of Neuroimaging at the Institute of Psychiatry, Psychology & Neuroscience, commented, “I’ve been involved with Hyperfine since the earliest days of portable MRI, and the relentless progress has been remarkable. With the next-generation Swoop® system, the improvement in image quality is transformative. Having spent my career exploring advanced brain imaging, I am impressed that low-field MRI can provide this level of diagnostic-quality images. For years, limited access to neuroimaging has delayed diagnosis and treatment for countless patients around the world. The Swoop® system is uniquely positioned to address that gap, making MRI accessible when and where it is needed, even in remote locations, to support decision-making in a wider range of care settings across the lifespan.”
Hyperfine also announced the inclusion of its next-generation Swoop® system (Model 2) in the UniHA procurement listing, a key milestone enabling broader adoption across hospitals within the French public healthcare system. The initial inclusion of the Swoop® system in this listing was in October 2025.
“We are proud to bring Hyperfine’s most advanced portable MRI technology to clinicians across Europe and the UK, delivering on an important milestone for our commercialization strategy in 2026,” said Eric Willis, Vice President of International at Hyperfine. “The next-generation system delivers significant improvements in image quality, workflow efficiency, and clinical capability. We have already seen these advancements accelerate use and adoption of the Swoop® system throughout the United States. We look forward to working closely with our distribution partners to expand access to AI-powered portable MRI across Europe, providing critical neuroimaging that helps clinicians make more timely and more informed patient care decisions. By the end of the year, we plan to make the Model 2 Swoop® system available through our distribution partners across all European markets where Hyperfine is represented.”
The European commercial launch adds to Hyperfine’s recent corporate momentum, including its inclusion in the Russell 2000® Index, as the company continues to expand global access to its AI-powered portable MRI technology.
For more information about the Swoop® system, please visit HyperfineMRI.com.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!